☰

Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results




Athens, 18 May 2014: Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...

Domingo, 18 de Mayo 2014
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección